Gabay Ariel J, Wang Jennifer, Boe Lillian A, Stern Carrie S, Mehrara Babak, Moo Tracy-Ann, Nelson Jonas A, Tadros Audree
Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ann Surg Oncol. 2025 Jul 12. doi: 10.1245/s10434-025-17782-z.
Psychiatric conditions are known to impact outcomes in breast reconstruction patients, but their effect on patient-reported outcomes in breast-conserving surgery (BCS) patients remains unclear. This study investigates how psychiatric diagnoses-both preexisting and post-cancer-affect BREAST-Q scores in BCS patients.
We conducted a retrospective review of patients who underwent BCS from 2017-2022 at Memorial Sloan Kettering, examining BREAST-Q scores collected in routine care preoperatively and annually for 3 years postoperatively. Patients were categorized as having no psychiatric diagnosis, a diagnosis before breast cancer, or a diagnosis after. Kruskal-Wallis and Wilcoxon tests compared scores, and multivariable linear mixed effects models adjusted for confounders.
Of 7937 patients, 273 were diagnosed before breast cancer, 2971 were diagnosed after, and 4693 had no history of psychiatric diagnosis. Among those with a psychiatric diagnosis, 81% had anxiety. Compared with patients without psychiatric diagnoses, those with diagnoses-pre- or post-cancer-reported significantly lower scores in Satisfaction with Breasts, Sexual Well-Being, and Psychosocial Well-Being (p < 0.001). No significant difference was observed in Physical Well-Being scores for precancer diagnoses (p = 0.4) compared with patients without psychiatric diagnoses. Precancer diagnoses were associated with more pronounced declines across most domains compared to postcancer diagnoses.
Psychiatric diagnoses are associated with lower BREAST-Q scores after BCS, especially when diagnosed before cancer. These findings emphasize the importance of integrated mental health support in optimizing quality of life for breast cancer patients.
已知精神疾病会影响乳房重建患者的治疗结果,但它们对保乳手术(BCS)患者报告的治疗结果的影响仍不明确。本研究调查了精神疾病诊断——包括癌症前已存在的和癌症后出现的——如何影响BCS患者的BREAST-Q评分。
我们对2017年至2022年在纪念斯隆凯特琳癌症中心接受BCS手术的患者进行了回顾性研究,检查术前常规护理以及术后3年每年收集的BREAST-Q评分。患者被分类为没有精神疾病诊断、乳腺癌前诊断或乳腺癌后诊断。采用Kruskal-Wallis检验和Wilcoxon检验比较评分,并使用多变量线性混合效应模型对混杂因素进行调整。
在7937名患者中,273名在乳腺癌前被诊断出患有精神疾病,2971名在乳腺癌后被诊断出患有精神疾病,4693名没有精神疾病诊断史。在有精神疾病诊断的患者中,81%患有焦虑症。与没有精神疾病诊断的患者相比,有癌症前或癌症后诊断的患者在乳房满意度、性健康和心理社会健康方面的评分显著更低(p < 0.001)。与没有精神疾病诊断的患者相比,癌症前诊断患者的身体健康评分没有显著差异(p = 0.4)。与癌症后诊断相比,癌症前诊断在大多数领域的下降更为明显。
精神疾病诊断与BCS术后较低的BREAST-Q评分相关,尤其是在癌症前被诊断出时。这些发现强调了综合心理健康支持对优化乳腺癌患者生活质量的重要性。